Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.
Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back.
Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.
Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests.
Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research.
Combining two different immunotherapy treatments could dramatically improve lymphoma survival.
Cancer Research UK scientists are developing a bubbly drink packed with oxygen microbubbles to make treatments more potent for hard to treat tumours.